CompoAtlas

Optimum Protection Women 50+

Natural health product licensed in Canada

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
1-Carboxy-N,N,N-chlorure de triméthylméthanaminium

Source : Tubercule

30 mgNot calculated
1-Carboxy-N,N,N-chlorure de triméthylméthanaminium

Source : Beta vulgaris

30 mgNot calculated
Fallopia japonica

Source : Root extract (standardised)

Potency : 50 % resveratrol

5 mgNot calculated
Folate

Source : Folate

1,000 mcgNot calculated
(3R,3'R,6'R)-beta,epsilon-Carotene-3,3'-diol

Source : L'oléorésine de Tagetes erecta

0.5 mgNot calculated
Chrome

Source : Chlorure chromique

200 mcgNot calculated
Inositol30 mgNot calculated
Cuivre

Source : Citrate de cuivre

1,000 mcgNot calculated
(3R,3'R)-bêta,bêta-Carotène-3,3'-diol

Source : L'oléorésine de Tagetes erecta

0.5 mgNot calculated
Vitamine B12

Source : Cyanocobalamine

100 mcgNot calculated
Iode

Source : Kelp thallus

200 mcgNot calculated
Potassium

Source : Citrate de potassium

35 mgNot calculated
Riboflavine

Source : Riboflavin 5'-phosphate de sodium

25 mgNot calculated
Bioflavonoïdes d'agrumes

Source : Citrus limon - Pelure (fruit)

45 mgNot calculated
Calcium

Source : Carbonate de calcium

175 mgNot calculated
Vitamine C

Source : Ascorbate de calcium

150 mgNot calculated
Equisetum arvense

Source : Plante

Potency : 7 % silica

30 mgNot calculated
3,3',4',5,7-Pentahydroxyflavone-3-rutinoside

Source : Dimorphandra mollis - fruit

15 mgNot calculated
Panax quinquefolius

Source : Root extract (standardised)

Potency : 5 % ginsenosides

15 mgNot calculated
Manganèse

Source : Manganous citrate

2 mgNot calculated
Magnésium

Source : Citrate de magnésium

1 mgNot calculated
Vitamine E

Source : D-alpha-tocophéryl succinate

Potency : 100 UI

67 mg ATNot calculated
Calcium

Source : Citrate de calcium

25 mgNot calculated
Acide pantothénique

Source : D-Pantothénate de calcium

25 mgNot calculated
Vitamine B6

Source : Pyridoxine HCl Pyridoxal-5-Phosphate

30 mgNot calculated

Non-medicinal ingredients

Stéarate de magnésium végétal, Croscarmellose de sodium, Dioxyde de silicium, Saveur de vanille naturelle, Microcrystalline cellulose, Acide stéarique

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Caplet1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

A factor and antioxidant for the maintenance of good health. Helps in connective tissue formation, the absorption and use of calcium and phosphorus, the development and maintenance of bones and teeth, the function of the thyroid gland, and the normal development and maintenance of bones and teeth. Helps to produce and repair connective tissue, wound healing, and normal growth and development. Helps prevent iodine, copper and pantothenic acid deficiency. Helps the body to metabolize carbohydrates, fats and proteins. Helps to form red blood cells. Helps to maintain proper muscle function. Source of vitamin A/Provitamin A to help maintain eyesight, skin membranes and immune function. Calcium intake, when combined with sufficient vitamin D, a healthy diet and regular exercise, may reduce the risk of developing osteoporosis. Adequate calcium as part of a healthy diet may help prevent bone loss/osteoporosis

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Product record

Licence holder
Lifeagen Biosciences of Florida Inc. dba Dr. Paul's Nutraceuticals
NPN or DIN-HM
80032377
Status
Inactive licence
Licence date
24 May 2012
Revision date
Not provided
Form
Caplet
Route of administration
Orale
Application type
Non traditionnelle

Source

Official Health Canada record, licence 80032377

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Panax quinquefolius
    Read the warning, when it applies and the studies cited

    PANAX QUINQUEFOLIUS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners or digoxin (Brinker 2010; Dasgupta et al. 2007; Elmer et al. 2007; Yuan et al. 2004).

    Sources cited by Health Canada (4)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Dasgupta A, Kang E, Olsen M, Actor JK, Datta P. Interference of Asian, American, and Indian (Ashwagandha) ginseng in serum digoxin measurements by a fluorescence polarization immunoassay can be minimized by using a new enzyme-linked chemiluminescent immunosorbent or turbidimetric assay. Archives of Pathology & Laboratory Medicine 2007;131(4):619-621. PubMed
    • Elmer GW, Lafferty WE, Tyree PT, Lind BK. Potential interactions between complementary/alternative products and conventional medicines in a Medicare population. The Annals of Pharmacotherapy 2007;41(10):1617-1624. PubMed
    • Yuan CS, Wei G, Dey L, Karrison T, Nahlik L, Maleckar S, Kasza K, Ang-Lee M, Moss J. American ginseng reduces warfarin's effect in healthy patients. Annals of internal medicine 2004;141(1):23-27. PubMed Randomised trial

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Dascalu et al. 2007; Vuksan et al. 2000a,b,c).

    Sources cited by Health Canada (3)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Dascalu A, Sievenpiper JL, Jenkins AL, Stavro MP, Leiter LA, Arnason JT, Vuksan V. Five batches representative of Ontario-grown American ginseng root produce comparable reductions of postprandial glycemia in healthy individuals. Canadian Journal of Physiology and Pharmacology 2007;85(9):856-864. PubMed
    • Vuksan V, Xu Z, Jenkins AL, Belgan U, Sievenpiper JL, Leiter LA, Josse RG, Stavro MP.American ginseng (Panax quinquefolium L.) improves long-term glycemic control in type 2 diabetes: double-blind placebo controlled crossover trial. Diabetes 2000a;49 (Suppl.1):A95.

    Condition of application: All products except Glucose levels and Adaptogen - immune system.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 30 January 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Optimum Protection Women 50+”, https://compoatlas.com/en/supplements/canada/80032377-optimum-protection-women-50, updated 24 May 2012.

Enter to analyse, Shift+Enter for a new line